Sayaka Kodaira

Clinical value of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis

Y. Tsushima, T. Higuchi, O. Ishikawa, 2019, The Journal of dermatology.

A case of intra-articular ganglion cysts of the knee joint: correlation between arthroscopic and magnetic resonance imaging

Ryosuke Takahashi, Yoshito Tsushima, Takahito Nakajima, 2016, BMC Medical Imaging.

Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease

K. Ishii, N. Hattori, Y. Tsushima, 2021, Frontiers in Neurology.

Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of 90Y-Ibritumomab Tiuxetan Response

Y. Tsushima, T. Higuchi, H. Handa, 2018, The Kitakanto Medical Journal.

CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and 11C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer’s disease

Y. Tsushima, K. Okamoto, M. Amari, 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Advantages of L-3-[18F] fluoro-alpha-methyl tyrosine over 2-[18F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan

Y. Tsushima, T. Higuchi, T. Nakajima, 2016, SpringerPlus.